Skip to main content
S 2282 114th Congress Senate Health Administrative law and regulatory procedures Blood and blood diseases Cell biology and embryology Department of Health and Human Services Health programs administration and funding Medical research Organ and tissue donation and transplantation Public contracts and procurement Research administration and funding

Stem Cell Therapeutic and Research Reauthorization Act of 2015

Introduced: November 16, 2015 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 16, 2015
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)
Nov 16, 2015
Introduced in Senate
 Plain-English summary Congressional Research Service

Stem Cell Therapeutic and Research Reauthorization Act of 2015

This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)

The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.

Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.

HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
What's happening now November 16, 2015

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S7968-7969)

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1